Immune Support Stack

Immune system optimization

Overview

Thymosin Alpha-1 enhances T-cell function and overall immune competence, while LL-37 provides direct antimicrobial activity and immune modulation. Suitable for immune compromised states or prevention.

Peptides

Thymosin Alpha-1 1.6mg 2-3x weekly

→

LL-37 0.075mg 1x daily (acute)

→

Protocol

Thymosin Alpha-1: 1.6-3.2mg 2-3x weekly. LL-37: 50-100mcg daily during acute need.

Notes

Thymosin Alpha-1 approved in 35+ countries with excellent safety record. LL-37 more experimental.